Stay updated on Daratumumab Combo Salvage Therapy in MM Clinical Trial
Sign up to get notified when there's something new on the Daratumumab Combo Salvage Therapy in MM Clinical Trial page.

Latest updates to the Daratumumab Combo Salvage Therapy in MM Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page has been updated to reflect a new version of the study protocol for Relapsed/Refractory Multiple Myeloma, with changes in the revision number and the removal of detailed study purpose and criteria. Collaborators have been retained in the new version.SummaryDifference36%
- Check20 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check27 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check63 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check77 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check85 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
Stay in the know with updates to Daratumumab Combo Salvage Therapy in MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab Combo Salvage Therapy in MM Clinical Trial page.